Search

everythinglearnresearchcommunity

for

Search:↓

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

Hyperandrogenism and insulin resistance in PCOS-like rats can lead to pregnancy complications due to increased cell death in the uterus and placenta.

Mutations in the POC1A gene can cause a unique form of extreme insulin resistance and short stature.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Early diagnosis, genetic testing, and innovative treatments are crucial for managing complex medical conditions.

Polycystic ovarian disease symptoms can continue after menopause, making diagnosis and management in older women challenging.

Testosterone metabolites may help relieve diabetic nerve pain.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Melatonin may help treat PCOS symptoms in rats.

Metformin promotes hair growth by affecting cell growth and protein signaling related to hair growth.

L-Selectin and adiponectin can help identify PCOS patients who respond to Metformin treatment.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

The effectiveness of statins for women with PCOS is unclear.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

THSG from a Chinese plant helps with aging and related diseases.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

NAG-1 may help prevent some metabolic issues related to PCOS.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

Lean and obese women with PCOS have similar levels of insulin resistance, indicating it's a core aspect of the condition.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.